The European AntibotABE Framework Program and Its Update: Development of Innovative Botulinum Antibodies

The goal of the AntiBotABE Program was the development of recombinant antibodies that neutralize botulinum neurotoxins (BoNT) A, B and E. These serotypes are lethal and responsible for most human botulinum cases. To improve therapeutic efficacy, the heavy and light chains (HC and LC) of the three Bo...

全面介绍

书目详细资料

发表在:	Toxins
Main Authors:	Christine Rasetti-Escargueil, Arnaud Avril, Sebastian Miethe, Christelle Mazuet, Yagmur Derman, Katja Selby, Philippe Thullier, Thibaut Pelat, Remi Urbain, Alexandre Fontayne, Hannu Korkeala, Dorothea Sesardic, Michael Hust, Michel R. Popoff
格式:	文件
语言:	英语
出版:	MDPI AG 2017-10-01
主题:	AntiBotABE botulinum toxin phage-display IgG neutralization botulism biodefense recombinant oligoclonal antibodies
在线阅读:	https://www.mdpi.com/2072-6651/9/10/309